We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
NLI Holdings
NL
$284M
| $237K | ﹤0.01% |
69,700
| – | – |
|
1602
Mueller Industries
MLI
$14.1B
| $236K | ﹤0.01% |
35,600
+2,800
| +9% | +$17.6K |
|
1603
Carrier Global
CARR
$57.2B
| $231K | ﹤0.01% |
+10,415
| New | +$194K |
|
1604
Evolution Petroleum
EPM
$137M
| $231K | ﹤0.01% |
82,600
+6,800
| +9% | +$18.3K |
|
1605
Repay Holdings
RPAY
$315M
| $231K | ﹤0.01% |
+9,400
| New | +$189K |
|
1606
NovaGold Resources
NG
$2.6B
| $229K | ﹤0.01% |
25,000
+6,500
| +35% | +$65.8K |
|
|
SWTX
1607
DELISTED
SpringWorks Therapeutics
SWTX
| $226K | ﹤0.01% |
5,400
+2,700
| +100% | +$96.1K |
|
|
BRSL
1608
Brightstar Lottery PLC
BRSL
$1.91B
| $225K | ﹤0.01% |
25,300
-47,053
| -65% | -$367K |
|
1609
SmartFinancial
SMBK
$855M
| $223K | ﹤0.01% |
13,800
+1,100
| +9% | +$16.1K |
|
|
NWLI
1610
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $223K | ﹤0.01% |
1,100
+100
| +10% | +$19.1K |
|
|
LADR
1611
Ladder Capital
LADR
$1.25B
| $222K | ﹤0.01% |
27,500
| – | – |
|
1612
Ormat Technologies
ORA
$6.11B
| $222K | ﹤0.01% |
3,500
-11,800
| -77% | -$772K |
|
1613
The Joint Corp
JYNT
$119M
| $221K | ﹤0.01% |
14,500
+1,100
| +8% | +$14.4K |
|
|
PVBC
1614
DELISTED
Provident Bancorp
PVBC
| $219K | ﹤0.01% |
+27,900
| New | +$241K |
|
1615
WD-40
WDFC
$3.1B
| $218K | ﹤0.01% |
1,100
-600
| -35% | -$109K |
|
|
TBIO
1616
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $218K | ﹤0.01% |
+12,200
| New | +$184K |
|
1617
BCB Bancorp
BCBP
$176M
| $215K | ﹤0.01% |
23,200
+1,900
| +9% | +$18.2K |
|
1618
First Bank
FRBA
$451M
| $215K | ﹤0.01% |
33,100
+2,700
| +9% | +$19.1K |
|
1619
Preformed Line Products
PLPC
$1.52B
| $215K | ﹤0.01% |
4,300
+400
| +10% | +$19.5K |
|
1620
Orion Energy Systems
OESX
$41.1M
| $214K | ﹤0.01% |
+6,200
| New | +$254K |
|
1621
Papa John's
PZZA
$999M
| $214K | ﹤0.01% |
2,700
-53,200
| -95% | -$3.96M |
|
1622
Siebert Financial
SIEB
$68M
| $214K | ﹤0.01% |
42,300
| – | – |
|
|
HARP
1623
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $214K | ﹤0.01% |
+1,290
| New | +$201K |
|
1624
nLIGHT
LASR
$3.95B
| $213K | ﹤0.01% |
+9,600
| New | +$182K |
|
1625
LSI Industries
LYTS
$853M
| $213K | ﹤0.01% |
+33,000
| New | +$190K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.